33:14duration 33 minutes 14 seconds
John Brognard - Tracking down the elusive dark…
John Brognard - Tracking down the elusive dark kinome to identify new cancer drug targets
Tony Hunter 50th Symposium
37:49duration 37 minutes 49 seconds
Ruth Palmer - What model organisms have taught us…
Ruth Palmer - What model organisms have taught us about the role of the ALK receptor tyrosine kinase in human neuroblastoma
42:16duration 42 minutes 16 seconds
Susan Taylor - How elucidating the structure of…
Susan Taylor - How elucidating the structure of the protein kinase A catalytic domain has enabled the development of selective kinase inhibitors
30:17duration 30 minutes 17 seconds
Manish Butte - Overcoming metabolic and…
Manish Butte - Overcoming metabolic and immunological limitations of the tumor microen vironment
LJIC 2024
26:49duration 26 minutes 49 seconds
John Teijaro - Modulating cytokine signaling…
John Teijaro - Modulating cytokine signaling networks to control persistent viral infections and cancer
01:28:16duration 1 hour 28 minutes
Tony Hunter - Oncogenes and Cell Signaling
UCSD Cancer Course.
01:14:53duration 1 hour 14 minutes
Tony Hunter – Oncogenes and Cell Signaling
01:23:08duration 1 hour 23 minutes
01:19:07duration 1 hour 19 minutes
Tony Hunter – Salk Cancer Course (BGGN 245)…
Tony Hunter – Salk Cancer Course (BGGN 245) Targeting deregulated protein phosphorylation pathways in cancer therapy
58:26duration 58 minutes 26 seconds
Benjamin Cravatt – Activity-Based…
Benjamin Cravatt – Activity-Based Proteomics — Applications For Enzyme and Inhibitor Discovery